Phytoform
Harpenden, GB · Delaware corporation · 8 known investors
Phytoform Labs develops GM-free genome editing tools and trait engineering technologies for crop improvement, with a focus on potato and tomato varieties. The company works at the intersection of biotechnology and agricultural research to advance sustainable crop breeding.
Founders & leadership
WP
William PeltonExecutive Officer, Director
NK
Nicholas KralDirector
DS
Dhiraj SinghDirector
Investors · 8
BackedLondon · $500K – $5M
Eniac VenturesNew York · $50K – $300K
Fine Structures VenturesCambridge
FTW VenturesSan Francisco · $100K – $500K
Manta Ray VenturesLondon
Wireframe VenturesSan Francisco · $500K – $2M
Refactor CapitalreportedBurlingame · $1M – $2M
Tet VenturesreportedBerlin · $50K – $250Kvia Neeraj Berry · inferred
Reported raises · per SEC filings
Form D private placements▶$5.8MraisedNov 2021 · 15 investors · Other TechnologyRule 506(b)
▶$5.8MraisedNov 2021 · 15 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- William PeltonExecutive Officer, Director
- Nicholas KralDirector
- Dhiraj SinghDirector
- Offering amount
- $5.8M
- Amount sold
- $5.8M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.